- Home
- NOTE vs HOWL Comparison
NOTE vs HOWL Comparison
Compare NOTE & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTE
- HOWL
- Stock Information
- Founded
- NOTE 2013
- HOWL 2017
- Country
- NOTE United States
- HOWL United States
- Employees
- NOTE N/A
- HOWL N/A
- Industry
- NOTE EDP Services
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- NOTE Technology
- HOWL Health Care
- Exchange
- NOTE Nasdaq
- HOWL Nasdaq
- Market Cap
- NOTE 65.4M
- HOWL 64.5M
- IPO Year
- NOTE N/A
- HOWL 2021
- Fundamental
- Price
- NOTE $5.29
- HOWL $1.88
- Analyst Decision
- NOTE Strong Buy
- HOWL Strong Buy
- Analyst Count
- NOTE 4
- HOWL 5
- Target Price
- NOTE $29.25
- HOWL $7.20
- AVG Volume (30 Days)
- NOTE 271.2K
- HOWL 1.4M
- Earning Date
- NOTE 11-11-2025
- HOWL 11-06-2025
- Dividend Yield
- NOTE N/A
- HOWL N/A
- EPS Growth
- NOTE N/A
- HOWL N/A
- EPS
- NOTE N/A
- HOWL N/A
- Revenue
- NOTE $109,683,000.00
- HOWL N/A
- Revenue This Year
- NOTE N/A
- HOWL N/A
- Revenue Next Year
- NOTE $41.76
- HOWL N/A
- P/E Ratio
- NOTE N/A
- HOWL N/A
- Revenue Growth
- NOTE N/A
- HOWL N/A
- 52 Week Low
- NOTE $3.80
- HOWL $0.60
- 52 Week High
- NOTE $24.36
- HOWL $4.18
- Technical
- Relative Strength Index (RSI)
- NOTE 68.08
- HOWL 71.75
- Support Level
- NOTE $4.90
- HOWL $1.92
- Resistance Level
- NOTE $5.40
- HOWL $2.15
- Average True Range (ATR)
- NOTE 0.34
- HOWL 0.17
- MACD
- NOTE -0.09
- HOWL 0.05
- Stochastic Oscillator
- NOTE 63.56
- HOWL 78.41
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.